alexa
Reach Us +1-504-608-2390
Chemotherapy In Retinoblastoma | 8428
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Chemotherapy in retinoblastoma

2nd International Conference on Clinical Research Cardiology, Ophthalmology & Dermatology

Muhammad Arif

Accepted Abstracts: J Clinic Experiment Ophthalmol

DOI: 10.4172/2155-9570.S1.05

Abstract
Retinoblastoma, Cr pediatric ocular malignant tumor is a potentially killing disease. It occurs most commonly below 05 years of age, usually presents with leukocoria. Early detection with prompt and accurate treatment is life saving as well as sight preserving. The management of retinoblastoma has been changing over the past 04 decades. Enucleation and external beam therapy used to be the favorite treatment in the distant past. Survival remained unpredictable for quite a long time. But during the last 02 decades the treatment of the disease has revolutionized through the introduction of different modes of chemotherapy. Chemo reduction with adjuvant local therapy has received world wide acceptance. Survival now has reached almost 95% in the developed world, although the developing countries still face miserable deaths resulting from retinoblastoma. There is still a ire need for accomplishing a complete cure, in the case of each child suffering from retinoblastoma. Further research in this respect still goes on.
Biography
Dr. Muhammad Arif is assistant professor and head of Ophthalmology in KUST Institute of Medical Sciences Kohat. He is director Medical Education and has series of publications on retinoblastoma in international and national journals of ophthalmology.
Top